Last reviewed · How we verify
Marketed Nicotine Lozenge
Marketed Nicotine Lozenge is a Small molecule drug developed by McNeil AB. It is currently in Phase 1 development. Also known as: NiQuitin™ lozenge.
At a glance
| Generic name | Marketed Nicotine Lozenge |
|---|---|
| Also known as | NiQuitin™ lozenge |
| Sponsor | McNeil AB |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pharmacokinetic Study of 4 mg Nicotine Lozenge. (PHASE2)
- A Single Dose Bioequivalence Study OfTwo Formulations Of Nicotine Lozenges (PHASE1)
- Multiple-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product. (NA)
- Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product (NA)
- Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge (PHASE2)
- Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products (PHASE1)
- Comparative Pharmacokinetic Study of New Oral Nicotine Replacement Therapy Products. (NA)
- Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement Products (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Marketed Nicotine Lozenge CI brief — competitive landscape report
- Marketed Nicotine Lozenge updates RSS · CI watch RSS
- McNeil AB portfolio CI
Frequently asked questions about Marketed Nicotine Lozenge
What is Marketed Nicotine Lozenge?
Marketed Nicotine Lozenge is a Small molecule drug developed by McNeil AB.
Who makes Marketed Nicotine Lozenge?
Marketed Nicotine Lozenge is developed by McNeil AB (see full McNeil AB pipeline at /company/mcneil-ab).
Is Marketed Nicotine Lozenge also known as anything else?
Marketed Nicotine Lozenge is also known as NiQuitin™ lozenge.
What development phase is Marketed Nicotine Lozenge in?
Marketed Nicotine Lozenge is in Phase 1.
Related
- Manufacturer: McNeil AB — full pipeline
- Also known as: NiQuitin™ lozenge
- Compare: Marketed Nicotine Lozenge vs similar drugs
- Pricing: Marketed Nicotine Lozenge cost, discount & access